Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes may be less welcome. Here's what to expect.
It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
Opinion: It’s time we prioritize innovation and invest in solutions that truly address the root cause of this chronic and ...
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices ...
Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...
Medicare covers costs associated with home health care, durable medical equipment, outpatient care and some preventative services, among other health care-related products and services ...
Most Medicare beneficiaries now receive their benefits ... hypertension, morbid obesity, and congestive heart failure are, on average, 15.4 percent higher than the average TM beneficiary.
Unfortunately, Medicare is forbidden to cover weight loss drugs for obesity unless patients possess another medical condition such as diabetes or cardiovascular disease. This policy prevents ...